CRISPR Therapeutics AG Insider Trading for April 2018

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in CRISPR Therapeutics AG.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of insider trading in CRISPR Therapeutics AG for April 2018.

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	50.03	779	38,973	100,780	101.6 K to 100.8 K (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	50.03	779	38,973	100,780	101.6 K to 100.8 K (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	50.01	333	16,653	43,067	43.4 K to 43.1 K (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	50.01	333	16,653	43,067	43.4 K to 43.1 K (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	50.08	300	15,024	38,852	39.2 K to 38.9 K (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	50.08	300	15,024	38,852	39.2 K to 38.9 K (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	50.02	10,236	512,005	1,324,194	1.3 M to 1.3 M (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	50.02	10,236	512,005	1,324,194	1.3 M to 1.3 M (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	50.11	14,086	705,849	101,559	115.6 K to 101.6 K (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	50.11	14,086	705,849	101,559	115.6 K to 101.6 K (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	50.12	6,019	301,672	43,400	49.4 K to 43.4 K (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	50.12	6,019	301,672	43,400	49.4 K to 43.4 K (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	50.12	5,430	272,152	39,152	44.6 K to 39.2 K (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	50.12	5,430	272,152	39,152	44.6 K to 39.2 K (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	50.11	185,075	9,274,108	1,334,430	1.5 M to 1.3 M (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	50.11	185,075	9,274,108	1,334,430	1.5 M to 1.3 M (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.03	779	38,973	100,780	101.6 K to 100.8 K (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.03	779	38,973	100,780	101.6 K to 100.8 K (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.01	333	16,653	43,067	43.4 K to 43.1 K (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.01	333	16,653	43,067	43.4 K to 43.1 K (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.08	300	15,024	38,852	39.2 K to 38.9 K (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.08	300	15,024	38,852	39.2 K to 38.9 K (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.02	10,236	512,005	1,324,194	1.3 M to 1.3 M (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.02	10,236	512,005	1,324,194	1.3 M to 1.3 M (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.11	14,086	705,849	101,559	115.6 K to 101.6 K (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.11	14,086	705,849	101,559	115.6 K to 101.6 K (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.12	6,019	301,672	43,400	49.4 K to 43.4 K (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.12	6,019	301,672	43,400	49.4 K to 43.4 K (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.12	5,430	272,152	39,152	44.6 K to 39.2 K (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.12	5,430	272,152	39,152	44.6 K to 39.2 K (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.11	185,075	9,274,108	1,334,430	1.5 M to 1.3 M (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.11	185,075	9,274,108	1,334,430	1.5 M to 1.3 M (-12.18 %)
Apr 26 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	51.00	1,528	77,928	115,645	117.2 K to 115.6 K (-1.30 %)
Apr 26 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	51.00	653	33,303	49,419	50.1 K to 49.4 K (-1.30 %)
Apr 26 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.60	589	29,803	44,582	45.2 K to 44.6 K (-1.30 %)
Apr 26 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	51.00	20,071	1,023,621	1,519,505	1.5 M to 1.5 M (-1.30 %)
Apr 26 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	51.00	1,528	77,928	115,645	117.2 K to 115.6 K (-1.30 %)
Apr 26 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	51.00	653	33,303	49,419	50.1 K to 49.4 K (-1.30 %)
Apr 26 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	50.60	589	29,803	44,582	45.2 K to 44.6 K (-1.30 %)
Apr 26 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	51.00	20,071	1,023,621	1,519,505	1.5 M to 1.5 M (-1.30 %)
Apr 26 2018	CRSP	CRISPR Therapeutic ...	Versant Venture Capital V, L.P ...	10% Owner	Sell	S	51.00	1,528	77,928	115,645	117.2 K to 115.6 K (-1.30 %)
Apr 26 2018	CRSP	CRISPR Therapeutic ...	Versant Venture Capital V, L.P ...	10% Owner	Sell	S	51.00	653	33,303	49,419	50.1 K to 49.4 K (-1.30 %)
Apr 26 2018	CRSP	CRISPR Therapeutic ...	Versant Venture Capital V, L.P ...	10% Owner	Sell	S	50.60	589	29,803	44,582	45.2 K to 44.6 K (-1.30 %)
Apr 26 2018	CRSP	CRISPR Therapeutic ...	Versant Venture Capital V, L.P ...	10% Owner	Sell	S	51.00	20,071	1,023,621	1,519,505	1.5 M to 1.5 M (-1.30 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Versant Venture Capital IV, L. ...	10% Owner	Sell	S	50.66	6,821	345,552	117,173	124 K to 117.2 K (-5.50 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Versant Venture Capital IV, L. ...	10% Owner	Sell	S	51.00	2,915	148,665	50,072	53 K to 50.1 K (-5.50 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Versant Venture Capital IV, L. ...	10% Owner	Sell	S	51.00	2,630	134,130	45,171	47.8 K to 45.2 K (-5.50 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Versant Venture Capital IV, L. ...	10% Owner	Sell	S	50.66	89,628	4,540,554	1,539,576	1.6 M to 1.5 M (-5.50 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Versant Venture Capital IV, L. ...	10% Owner	Sell	J	0.00	92,918	0	0	92.9 K to 0 (-100.00 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Versant Venture Capital IV, L. ...	10% Owner	Buy	J	0.00	92,918	0	92,918	0 to 92.9 K
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Versant Venture Capital IV, L. ...	10% Owner	Sell	J	0.00	2,947	0	13,277	16.2 K to 13.3 K (-18.16 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Versant Venture Capital IV, L. ...	10% Owner	Sell	J	0.00	497,053	0	2,238,979	2.7 M to 2.2 M (-18.17 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.66	6,821	345,552	117,173	124 K to 117.2 K (-5.50 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	51.00	2,915	148,665	50,072	53 K to 50.1 K (-5.50 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	51.00	2,630	134,130	45,171	47.8 K to 45.2 K (-5.50 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.66	89,628	4,540,554	1,539,576	1.6 M to 1.5 M (-5.50 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	J	0.00	2,323	0	7,282	5 K to 7.3 K (+46.84 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	J	0.00	92,918	0	0	92.9 K to 0 (-100.00 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	J	0.00	92,918	0	92,918	0 to 92.9 K
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	J	0.00	2,947	0	13,277	16.2 K to 13.3 K (-18.16 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	J	0.00	497,053	0	2,238,979	2.7 M to 2.2 M (-18.17 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	50.66	6,821	345,552	117,173	124 K to 117.2 K (-5.50 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	51.00	2,915	148,665	50,072	53 K to 50.1 K (-5.50 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	51.00	2,630	134,130	45,171	47.8 K to 45.2 K (-5.50 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	S	50.66	89,628	4,540,554	1,539,576	1.6 M to 1.5 M (-5.50 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Buy	J	0.00	16,262	0	43,986	27.7 K to 44 K (+58.66 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	J	0.00	92,918	0	0	92.9 K to 0 (-100.00 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Buy	J	0.00	92,918	0	92,918	0 to 92.9 K
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	J	0.00	2,947	0	13,277	16.2 K to 13.3 K (-18.16 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Bolzon Bradley J PhD	Director	Sell	J	0.00	497,053	0	2,238,979	2.7 M to 2.2 M (-18.17 %)
Apr 18 2018	CRSP	CRISPR Therapeutic ...	Kulkarni Samarth	Chief Executive Off ...	Option Exercise	A	19.12	75,000	1,434,000	150,000
Apr 18 2018	CRSP	CRISPR Therapeutic ...	Kulkarni Samarth	Chief Executive Off ...	Option Exercise	A	19.12	75,000	1,434,000	150,000